(Q54581100)
Statements
Imatinib mesylate discontinuation in patients with chronic myelogenous leukemia in complete molecular remission for more than 2 years. (English)
1 reference
1 reference
Eliane Gluckman
1 reference
Philippe Rousselot
1 reference
Francoise Huguet
1 reference
Laurence Legros
1 reference
Jean Michel Cayuela
1 reference
Odile Maarek
1 reference
Odile Blanchet
1 reference
Gerald Marit
1 reference
Josy Reiffers
1 reference
Martine Gardembas
1 reference
François-Xavier Mahon
1 reference
14 September 2006
1 reference
1 reference
109
1 reference
58-60
1 reference
1
1 reference
Identifiers
1 reference